Abstract Aims: To determine the effect of pregnancy on C4d concentrations and to assess whether C4d remains a useful disease activity marker in the management of connective tissue diseases during pregnancy. Methods: Plasma C3, C4, and C4d concentrations were measured in 83 women at various stages of normal pregnancy and compared with those in 80 nonpregnant controls. Results: C3 concentrations in the pregnant women were significantly raised (p = 0-0001) and the C4 concentrations were reduced (p = 0 0007), and accompanied by a significant increase in C4d (p = 0-0001). The C4d:C4 ratio was higher in the pregnant women (p = 01)001). C3 and C4 concentrations were measured using a turbidometric assay on a centrifugal fast analyser. C4d concentration was quantified using rocket immunoelectrophoresis, based on the method of Nitsche et al,7 using an anti-human C4 whole (Behring) where the faster rocket is C4d. After drying and staining, the rocket heights were measured and C4d values calculated from a standard curve. The C4d concentration of the standard (normal serum plus heat aggregated IgG, incubated at 37°C for one hour) was assigned an arbitary value of 100 Units/ml. C4d:C4 ratios were calculated for both groups to give indices of complement activation independent of the initial concentration of C4.2
Activation of the complement system is considered to be central to the inflammatory mechanisms in systemic lupus erythematosus (SLE). The measurement of complement breakdown products gives a quantitative assessment of such activation and has become established in some centres as a marker of disease activity. C3dg is a product of C3 activation by both the classical and the alternative pathway; C4d is a product of C4 activation by the C3 and C4 concentrations were measured using a turbidometric assay on a centrifugal fast analyser. C4d concentration was quantified using rocket immunoelectrophoresis, based on the method of Nitsche et al,7 using an anti-human C4 whole (Behring) where the faster rocket is C4d. After drying and staining, the rocket heights were measured and C4d values calculated from a standard curve. The C4d concentration of the standard (normal serum plus heat aggregated IgG, incubated at 37°C for one hour) was assigned an arbitary value of 100 Units/ml. C4d:C4 ratios were calculated for both groups to give indices of complement activation independent of the initial concentration of C4.2
Results were expressed as mean (SD) and the results from groups compared using Student's t test. Correlation coefficients were calculated using the Spearman's method.
Results
C3 concentrations were significantly higher in the pregnant women compared with controls Units/ml (mean 2 SD). Mean C4d value the pregnant women were 28-1 (10-8) UI ml, the difference between groups being nificant (t = 12-3, p = 0-0001). Compar of C4d concentrations among the pregi women with normal women aged 16-42 y only also showed a significant differt (t = 5-2, p = 0-0001). Figure 2 shows values in relation to the duration of p nancy. Although there was a positive coff tion between C4 and C4d concentration the pregnant women (Rho = +0 35), mean C4d:C4 ratios were greater in pregi women than in the normal group (t = 1 p = 0-0001) confirming that complen activation was taking place. Discussion A significant degree of C4 activation in plasma of healthy pregnant women indicated by the increase in the C4 conver product C4d and the higher fracti catabolic rate (C4d:C4). This C4 activa had occurred by the early part of the sec trimester of pregnancy. The effect of incr ing gestation on C4d concentrations individual patients was not studied. Furtl more, patients were not followed to term is not known whether particularly concentrations of C4d are associated N complications later on in pregnancy. Altho the pregnant women were compared with a control group of men and women of a wider range, no effect of either gender or age on C4d concentrations was found in our laboratory (data not shown). 
